A year ago, Ozempic (Novo Nordisk) dominated this space almost alone
Martnez-Jimnez F, Muios F, Sents I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, et al
Additionally, those with recurrent severe hypoglycemia episodes despite careful insulin management may face unacceptable risk, since semaglutide further sensitizes the body to blood-sugar-lowering medications
5 mg vials the underdosing trap
Wright commented that [t]he precise mechanism of these improvements remains speculative but does not appear to be purely related to weight loss. Indeed, he added, much of the benefit in these patients with heart failure seemed to be manifest prior to any substantial weight loss, strongly suggesting that the GLP-1 receptor agonist led to improvements in the metabolic syndrome and the heart failure syndrome, independent and perhaps additive to those expected from weight loss. Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, not involved in this research, welcomed its findings